DF

David Fisher

Dr Fisher is a founding partner of Brandon Capital Partners, an Australian venture capital provider. Dr Fisher has more than 35 years of operating experience in the biotechnology and healthcare industry in Australia and overseas. He held senior positions with Pharmacia AB (now part of Pfizer, Inc) and was CEO of Peptech Limited (now part of Cephalon Inc, (Nasdaq:CEPH). He is also member of Innovation and Development Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NAN
NAN
30/06/24203,940N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NAN
NAN
07/06/24
Sell
100,000$3.038$303,769On-market trade
NAN
NAN
08/03/23
Sell
110,000$4.581$503,937On-market trade
NAN
NAN
26/04/19
Sell
40,000$4.573$182,909On-market trade.
NAN
NAN
13/09/18
Transfer
188,424$3.200$602,956Off-market transfer. Assuming 188,424 indirect shares transferred to direct shares.
NAN
NAN
13/09/18
Sell
50,000$3.265$163,259On-market trade.